Moderna announces new supply agreement with Israel for 2022

Moderna, Inc., a US based biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced...

April 22, 2021 | Thursday | News
Prestige Biopharma to open vaccine production centre in South Korea

Prestige Biopharma Limited (PBP), based in Singapore, has announced that the company will be introducing a vaccine devel...

April 20, 2021 | Tuesday | News
Sputnik V vaccine receives authorization in India

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General o...

April 13, 2021 | Tuesday | News
GSK to provide fill and finish capacity for Novavax’ COVID-19 vaccine

  Novavax Inc, GlaxoSmithKline (GSK) and the UK Government Vaccines Taskforce have reached an agreement i...

April 12, 2021 | Monday | News
Sanofi invests in Asia's first digitally-enabled vaccine production center in Singapore

Sanofi has announced a €400 million investment over five years to create a unique vaccine production center in Sing...

April 12, 2021 | Monday | News
Celonic and CureVac to manufacture 100 Million doses of CVnCoV

Germany based CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on mess...

April 12, 2021 | Monday | News
Australia approves wider storage conditions for Pfizer COVID-19 vaccine

The Therapeutic Goods Administration (TGA) in Australia has recently approved wider storage and transportation condition...

April 12, 2021 | Monday | News
Korea pushes R&D of infectious disease therapeutics and vaccines

The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) have signed a memorandum of understanding...

April 12, 2021 | Monday | News
CanSinoBIO's single-dose COVID-19 vaccine gets approval in Chile

China based CanSino Biologics Inc. has announced that the Instituto de Salud Pública de ...

April 9, 2021 | Friday | News
South Korea approves J&J COVID-19 vaccine

South Korea’s Food and Drug Safety Ministry has granted final approval for the use of Johnson & Johnson’...

April 7, 2021 | Wednesday | News
Germany tests mutation-specific vaccine against malignant brain tumors

Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typi...

April 7, 2021 | Wednesday | News
HOPE Consortium kick starts World Immunisation & Logistics Summit in Dubai

The HOPE Consortium’s World Immunisation & Logistics Summit opened on March 30, 2021 by H.H. Sheikh Abdul...

March 30, 2021 | Tuesday | News
EU evaluates Takeda's dengue vaccine candidate

Takeda Pharmaceutical Company Limited has announced that the European Medicines Agency (EMA) has accepted the compa...

March 26, 2021 | Friday | News
AZD1222 US Phase III primary analysis confirms safety and efficacy

Positive high-level results from the primary analysis of the Phase III trial of AZD1222 in the US have confirmed vaccine...

March 25, 2021 | Thursday | News
Gavi board approves COVAX buffer for high-risk groups in humanitarian settings

The Board of Gavi, the Vaccine Alliance on March 23, 2021, has approved the COVAX Buffer to ensure access to C...

March 24, 2021 | Wednesday | News
CanSinoBIO's single-dose COVID-19 vaccine Convidecia™ receives approval in Hungary

CanSinoBIO Biologics Inc. announced that the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) grant...

March 23, 2021 | Tuesday | News
Daiichi Sankyo starts Ph 1/2 trial for mRNA COVID-19 vaccine in Japan

Daiichi Sankyo Company, Limited has announced that it has started the first vaccinations in a phase 1/2 clinical trial i...

March 23, 2021 | Tuesday | News
Australia approves CSL - Seqirus to manufacture AstraZeneca COVID-19 vaccine

The Therapeutic Goods Administration (TGA) has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in A...

March 22, 2021 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls